[1] Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., … & Fridkin, S. K. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the american medical association, 298(15), 1763–1771. DOI:10.1001/jama.298.15.1763
[2] Sethi, S. (2002). Bacterial pneumonia: Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics, 57(3), 56–61.
[3] Moreillon, P., Que, Y. A., & Bayer, A. S. (2002). Pathogenesis of streptococcal and staphylococcal endocarditis. Infectious disease clinics of north america, 16(2), 297–318. DOI:10.1016/S0891-5520(01)00009-5
[4] Normanno, G., La Salandra, G., Dambrosio, A., Quaglia, N. C., Corrente, M., Parisi, A., … & Celano, G. V. (2007). Occurrence, characterization and antimicrobial resistance of enterotoxigenic Staphylococcus aureus isolated from meat and dairy products. International journal of food microbiology, 115(3), 290–296. DOI:10.1016/j.ijfoodmicro.2006.10.049
[5] Witte, W., Strommenger, B., Cuny, C., Heuck, D., & Nuebel, U. (2007). Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. Journal of antimicrobial chemotherapy, 60(6), 1258–1263. DOI:10.1093/jac/dkm384
[6] Nikaido, H. (1998). Multiple antibiotic resistance and efflux. Current opinion in microbiology, 1(5), 516–523. DOI:10.1016/S1369-5274(98)80083-0
[7] Acar, J. F., & Goldstein, F. W. (1997). Trends in bacterial resistance to fluoroquinolones. Clinical infectious diseases, 24(1), S67--S73. DOI:10.1093/clinids/24.supplement_1.s67
[8] Marangon, F. B., Miller, D., Muallem, M. S., Romano, A. C., & Alfonso, E. C. (2004). Ciprofloxacin and levofloxacin resistance among methicillin-sensitive staphylococcus aureus isolates from keratitis and conjunctivitis. American journal of ophthalmology, 137(3), 453–458. DOI:10.1016/j.ajo.2003.10.026
[9] Coskun-Ari, F. F., & Bosgelmez-Tinaz, G. (2008). Grla and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin-methicillin-resistant staphylococcus aureus. European journal of medical research, 13(8), 366–370.
[10] Ito, H., Yoshida, H., Bogaki-Shonai, M., Niga, T., Hattori, H., & Nakamura, S. (1994). Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 38(9), 2014–2023. DOI:10.1128/AAC.38.9.2014
[11] Ouellette, M., Légaré, D., & Papadopoulou, B. (1994). Microbial multidrug-resistance ABC transporters. Trends in microbiology, 2(10), 407–411.
[12] Del Giudice, P., Bes, M., Hubiche, T., Roudiàre, L., Blanc, V., Lina, G., … & Etienne, J. (2011). Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV. Journal of the european academy of dermatology and venereology, 25(2), 164–169. DOI:10.1111/j.1468-3083.2010.03731.x
[13] Davoodi, N. R., Siadat, S. D., Vaziri, F., Yousefi, J. V., Harzandi, N., Rafi, A., … & Bahrmand, A. R. (2015). Identification of staphylococcus aureus and coagulase-negative Staphylococcus (CoNs) as well as detection of methicillin resistance and Panton-Valentine Leucocidin by multiplex PCR. Journal of pure and applied microbiology, 9(1), 467–471.
[14] Chikkala, R., George, N. O., Ratnakar, K. S., Iyer, R. N., & Sritharan, V. (2012). Heterogeneity in femA in the Indian isolates of Staphylococcus aureus limits its usefulness as a species specific marker. Advances in infectious diseases, 2(03), 82–88.
[15] Al-Talib, H., Yean, C. Y., Al-Khateeb, A., Hasan, H., & Ravichandran, M. (2014). Rapid detection of methicillin-resistant Staphylococcus aureus by a newly developed dry reagent-based polymerase chain reaction assay. Journal of microbiology, immunology and infection, 47(6), 484–490. DOI:10.1016/j.jmii.2013.06.004
[16] Al-Talib, H., Yean, C. Y., Al-Khateeb, A., Hassan, H., Singh, K. K. B., Al-Jashamy, K., & Ravichandran, M. (2009). A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and panton-valentine leucocidin. BMC microbiology, 9, 1–8. DOI:10.1186/1471-2180-9-113
[17] Theis, T., Skurray, R. A., & Brown, M. H. (2007). Identification of suitable internal controls to study expression of a Staphylococcus aureus multidrug resistance system by quantitative real-time PCR. Journal of microbiological methods, 70(2), 355–362. DOI:10.1016/j.mimet.2007.05.011
[18] Bremser, W. G., & Barsky, N. P. (2004). Utilizing the balanced scorecard for R&D performance measurement. R and d management, 34(3), 229–238. DOI:10.1111/j.1467-9310.2004.00335.x
[19] Dinges, M. M., Orwin, P. M., & Schlievert, P. M. (2000). Exotoxins of Staphylococcus aureus. Clinical microbiology reviews, 13(1), 16–34. DOI:10.1128/CMR.13.1.16-34.2000
[20] Holden, M. T. G., Feil, E. J., Lindsay, J. A., Peacock, S. J., Day, N. P. J., Enright, M. C., … & Parkhill, J. (2004). Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the evolution of virulence and drug resistance. Proceedings of the national academy of sciences of the United States of America, 101(26), 9786–9791. DOI:10.1073/pnas.0402521101
[21] Vannuffel, P., Laterre, P. F., Bouyer, M., Gigi, J., Vandercam, B., Reynaert, M., & Gala, J. L. (1998). Rapid and specific molecular identification of methicillin-resistant Staphylococcus aureus in endotracheal aspirates from mechanically ventilated patients. Journal of clinical microbiology, 36(8), 2366–2368. DOI:10.1128/jcm.36.8.2366-2368.1998
[22] Mehrotra, M., Wang, G., & Johnson, W. M. (2000). Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. Journal of clinical microbiology, 38(3), 1032–1035. DOI:10.1128/jcm.38.3.1032-1035.2000
[23] Abimanyu, N., Krishnan, A., Murugesan, S., Gurumurthy, S., Krishnan, P., & others. (2013). Use of triplex PCR for rapid detection of PVL and differentiation of MRSA from methicillin resistant coagulase negative staphylococci. Journal of clinical and diagnostic research (JCDR), 7(2), 215. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592277/
[24] Johnson, S., Krüger, D., & Labischinski, H. (1995). FemA of Staphylococcus aureus: Isolation and immunodetection. FEMS microbiology letters, 132(3), 221–228. DOI:10.1016/0378-1097(95)00314-U
[25] Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., … & Raviglione, M. C. (2001). Global trends in resistance to antituberculosis drugs. New england journal of medicine, 344(17), 1294–1303. DOI:10.1056/nejm200104263441706
[26] Ferber, D. (2002). Antibiotic resistance: Livestock feed ban preserves drugs’ power. Science, 295(5552), 27–28. DOI:10.1126/science.295.5552.27a
[27] Rahimi, F., Bouzari, M., Katouli, M., & Pourshafie, M. R. (2013). Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. Jundishapur journal of microbiology, 6(2), 144–149. DOI:10.5812/jjm.4896
[28] Gade, N. D., & Qazi, M. S. (2013). Fluoroquinolone therapy in Staphylococcus aureus infections: where do we stand? Journal of laboratory physicians, 5(02), 109–112. DOI:10.4103/0974-2727.119862
[29] Rezazadeh, M., Yousefi Mashouf, R., Sarmadyan, H., & Ghaznavi-Rad, E. (2013). Antibiotic profile of methicillin-resistant Staphylococcus aureus with multiple-drug resistances isolated from nosocomial infections in Vali-Asr Hospital of Arak. Journal of arak university of medical sciences, 16(2), 29–37.
[30] Aligholi, M., Emaneini, M., Hashemi, F. B., Shasavan, S., Jebelameli, F., & Kazemi, B. (2006). Determination of antimicrobial resistance pattern of Staphylococcus aureus isolated from clinical specimens. Tehran university medical journal, 64(9), 26–32. (In Persian). http://diglib.tums.ac.ir/pub/index.asp
[31] Shittu, A. O., Okon, K., Adesida, S., Oyedara, O., Witte, W., Strommenger, B., … Nübel, U. (2011). Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC microbiology, 11, 1–8. DOI:10.1186/1471-2180-11-92
[32] Soltan Dallal, M. M., Agha Amiri, S., Eshraghian, M., Sabour Yaraghi, A. A., Faramarzi, T., Mahdavi, V., Saberpour, F., Fazeli Fard, P., & Peymane Abedi, T. (2008). Prevalence and antibiotic resistance pattern of staphylococcus aureus strains isolated from food stuff. Journal of advances in medical and biomedical research, 16(4), 63. (In Persian). https://www.magiran.com/paper/590777/
[33] Pirmoradian, M., Pourbabaei, A., Sangi, M. G., & Kalhor, N. (2013). A clinical trial of contamination of surgical instruments with Staphylococcus aureus during long time orthopedic surgeries. Qom university of medical sciences journal, 7(3), Pe62–Pe70. (In Persian). http://journal.muq.ac.ir
[34] Nimmo, G. R., Bell, J. M., Mitchell, D., Gosbell, I. B., Pearman, J. W., & Turnidge, J. D. (2003). Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999. Microbial drug resistance, 9(2), 155–160.
[35] Picot, S., Rakotomalala, R. S., Farny, K., Simac, C., & Michault, A. (2010). Evolution de la résistance aux antibiotiques de 1997 à 2005 à la Réunion. Medecine et maladies infectieuses, 40(11), 617–624. DOI:10.1016/j.medmal.2010.04.001
[36] Poole, K. (2000). Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrobial agents and chemotherapy, 44(9), 2233–2241. DOI:10.1128/AAC.44.9.2233-2241.2000
[37] Hancock, R. E. W. (1997). The bacterial outer membrane as a drug barrier. Trends in microbiology, 5(1), 37–42. DOI:10.1016/S0966-842X(97)81773-8
[38] Hooper, D. C. (2000). Mechanisms of action and resistance of older and newer fluoroquinolones. Clinical infectious diseases, 31(SUPPL. 2), S24--S28. DOI:10.1086/314056
[39] Thomson, K. S., & Smith Moland, E. (2000). Version 2000: The new β-lactamases of Gram-negative bacteria at the dawn of the new millennium. Microbes and infection, 2(10), 1225–1235. DOI:10.1016/S1286-4579(00)01276-4
[40] Ding, Y., Onodera, Y., Lee, J. C., & Hooper, D. C. (2008). NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. Journal of bacteriology, 190(21), 7123–7129. DOI:10.1128/JB.00655-08
[41] Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005). MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. Journal of bacteriology, 187(7), 2395–2405. DOI:10.1128/JB.187.7.2395-2405.2005
)